Gilead Sciences, Inc. (FRA:GIS)
100.18
+0.71 (0.71%)
At close: Aug 22, 2025
Gilead Sciences Employees
Gilead Sciences had 17,600 employees as of December 31, 2024. The number of employees decreased by 400 or -2.22% compared to the previous year.
Employees
17,600
Change (1Y)
-400
Growth (1Y)
-2.22%
Revenue / Employee
€1,396,412
Profits / Employee
€305,330
Market Cap
121.43B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 17,600 | -400 | -2.22% |
Dec 31, 2023 | 18,000 | 1,000 | 5.88% |
Dec 31, 2022 | 17,000 | 2,600 | 18.06% |
Dec 31, 2021 | 14,400 | 800 | 5.88% |
Dec 31, 2020 | 13,600 | 1,800 | 15.25% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
SAP SE | 109,121 |
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 198,194 |
Allianz SE | 156,626 |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
Siemens Energy AG | 98,000 |
Rheinmetall AG | 28,539 |
Deutsche Bank Aktiengesellschaft | 89,753 |
Gilead Sciences News
- 2 days ago - Gildea's Kite Pharma Just Acquired Interius—$350 Million Move Shakes Up Cancer Therapy - Benzinga
- 2 days ago - Gilead unit to acquire cell therapy developer Interius for $350 million - Reuters
- 2 days ago - Gilead Topples On A Surprise Setback For Its 99.9% Effective HIV Drug - Investor's Business Daily
- 2 days ago - Gilead's Kite buying Interius BioTherapeutics for $350M - Seeking Alpha
- 2 days ago - CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans - Benzinga
- 2 days ago - CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans - Benzinga
- 2 days ago - Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform - Business Wire
- 2 days ago - CVS Health reportedly excludes coverage for Gilead’s new HIV drug for now - Seeking Alpha